Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs Needle syringe programmes (NSP) and opioid substitution therapy (OST) are ...

ATLANTA — Braves right-hander Spencer Schwellenbach broke his right elbow during a start last weekend and was placed on the 15-day injured list Wednesday as left fielder Jurickson Profar returned from ...

Braves right-hander Spencer Schwellenbach broke his right elbow during a start last weekend and was placed on the 15-day injured list Wednesday as left fielder Jurickson Profar returned from an 80 ...

Part of Jeff Bezos and Lauren Sánchez’s wedding invite has been revealed, setting social media ablaze. The couple is reportedly tying the knot this week in Venice in a wedding rumored to be ...

He described the event as an important opportunity to highlight the dangers posed by drug abuse and to showcase the national efforts in prevention, enforcement, international cooperation ...

SAMHSA has fought drug and mental health crises. Now it’s in crisis. Staff and budget cuts will result in fewer services for people fighting mental illness and addiction, including Narcan ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable for lower resource countries?

A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of HIV.

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease.

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

FDA approves powerful HIV drug that nearly eliminated spread in clinical trials The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to ...

Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo.